BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
PPARA
,
Metabolism of xenobiotics
,
Breast Cancer
,
Kidney
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
chromatin silencing complex
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Adrenal gland cortex
Testes
Colon
Small intestine
Kidney
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Rhinitis
Hemorrhagic shock
Smoker
Wound of skin
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
edoxudin
flavopiridol
BMS 387032
CGP 60474
A 443654
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Relb
ZNF788
CCDC170
CDC25C
FN1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Directionality of noncoding human RNAs: how to avoid artifacts.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Da…
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy
Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leu…
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With …
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ